Strain Report – Serious Seeds – Kali Mist by GBI
Heavy-weight sativa queen with a perfectly female appearance
Heavy-weight sativa queen with a perfectly female appearance
Eric and Michelle Crawford have been traveling to Frankfort for several years trying to gain support from state legislators for the legalization of medical cannabis
Cannabis buds and extracts as well as synthetic cannabinoids have been available on prescription to patients with severe diseases since March 2017, with the costs covered by health insurance companies.The prescription of medical marihuana is not restricted to specific symptoms and is therefore also valid for patients with Parkinson’s disease. From a legal perspective, patients who are seriously ill even have the right to be treated with cannabis if standard treatment methods are unsuccessful or result in unbearable side effects. This also applies even if only a slight chance of noticeable improvement is predicted as a result of the cannabis treatment.
Neil Paine a former soldier who served in Northern Ireland during the Troubles advocates the use of cannabis for medicinal purposes
Weed to deal with morning sickness. Thoughts?
The US has always had a turbulent relationship with cannabis. The substance has often been portrayed as a villainous, addictive, mind-altering drug, with harrowing consequences if used even once,
Health Minister Andrew Green confirmed last year that following advice from the Jersey Misuse of Drugs Advisory Council he was looking into legalising certain medicinal cannabis products and added that he could lodge proposals to legalise certain medicines before the end of 2017.
even though dope consumption is now legal in the state, non-citizens could still land themselves in hot water for indulging. It could have serious consequences should you ever wish to live there full-time.
Visitors will eventually tour the facilities where small farmers test, dry, cure, trim, process, and package marijuana for distribution
In many health settings, administration of medicinal cannabis poses significant implementation barriers including drug storage and safety for administering staff and surrounding patients. Different modes of administration also provide different yet potentially significant issues. One route that has become of clinical interest owing to the rapid onset of action and patient control of the inhaled amount (via breath timing and depth) is that of vaporisation of cannabinoid products. Although requiring a registered therapeutic device for administration, this is a relatively safe method of intrapulmonary administration that may be particularly useful for patients with difficulty swallowing, and for those in whom higher concentrations of cannabinoids are needed quickly. Research results are reassuring for hospital and clinical trial practices with staff administering vaporised cannabinoid products, and helpful to ethics committees wishing to quantify risk.